Format
Items per page
Sort by

Send to:

Choose Destination

Results: 7

1.

The KLK5 protease suppresses breast cancer by repressing the mevalonate pathway.

Pampalakis G, Obasuyi O, Papadodima O, Chatziioannou A, Zoumpourlis V, Sotiropoulou G.

Oncotarget. 2014 May 15;5(9):2390-403.

2.

HuR-regulated mRNAs associated with nuclear hnRNP A1-RNP complexes.

Papadodima O, Chatziioannou A, Patrinou-Georgoula M, Kolisis FN, Pletsa V, Guialis A.

Int J Mol Sci. 2013 Oct 11;14(10):20256-81. doi: 10.3390/ijms141020256.

3.

A comparative genomic study in schizophrenic and in bipolar disorder patients, based on microarray expression profiling meta-analysis.

Logotheti M, Papadodima O, Venizelos N, Chatziioannou A, Kolisis F.

ScientificWorldJournal. 2013;2013:685917. doi: 10.1155/2013/685917. Epub 2013 Mar 10.

4.

Application of an integrative computational framework in trancriptomic data of atherosclerotic mice suggests numerous molecular players.

Papadodima O, Sirsjö A, Kolisis FN, Chatziioannou A.

Adv Bioinformatics. 2012;2012:453513. doi: 10.1155/2012/453513. Epub 2012 Nov 6.

5.

A transcriptomic computational analysis of mastic oil-treated Lewis lung carcinomas reveals molecular mechanisms targeting tumor cell growth and survival.

Moulos P, Papadodima O, Chatziioannou A, Loutrari H, Roussos C, Kolisis FN.

BMC Med Genomics. 2009 Dec 15;2:68. doi: 10.1186/1755-8794-2-68.

6.

BM88/Cend1 is involved in histone deacetylase inhibition-mediated growth arrest and differentiation of neuroblastoma cells.

Politis PK, Akrivou S, Hurel C, Papadodima O, Matsas R.

FEBS Lett. 2008 Mar 5;582(5):741-8. doi: 10.1016/j.febslet.2008.01.052. Epub 2008 Feb 5.

7.

Characterization of the BM88 promoter and identification of an 88 bp fragment sufficient to drive neurone-specific expression.

Papadodima O, Sergaki M, Hurel C, Mamalaki A, Matsas R.

J Neurochem. 2005 Oct;95(1):146-59.

PMID:
16181419
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk